1 | 7-beta-Hydroxyepiandrosterone | 7-beta-hydroxyepiandrosterone 1件: 7-beta-hydroxyepiandrosterone; | - |
- |
- |
006 1件: 6 💬 |
2 | 8-hydroxy-2'-deoxyguanosine | - | - |
- |
- |
006 1件: 6 💬 |
3 | Acamprosate | Acamprosate 1件: Acamprosate; | 2件: D02780 D02780
D07058 D07058 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 2件: 6 , 206 💬 |
4 | Acetaminophen | Acetaminophen 9件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen tablets; Acetaminophen/paracetamol; Multi-modal pain management [acetaminophen + gabapentin]; Oxycodone/acetaminophen; Paracetamol (acetaminophen); Tramadol /acetaminophen; Tramadol hydrochloride + acetaminophen; | 1件: D00217 D00217 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 16件: 3 , 6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
5 | Acetate | 11c-acetate 98件: 11c-acetate; 2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester; 20mg/0.5ml glatiramer acetate; 40 mg glatiramer acetate; 90 mg hydrocortisone acetate suppository with sephure suppository applicator; Abiraterone acetate; Acetate; Bazedoxifene acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Caspofungin acetate; Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Cosyntropin acetate; Cyclophosphamide/glatiramer acetate; Delmitide acetate; Depot leuprolide acetate 3.75 mg; Desmopressin acetate; Desmopressin acetate trihydrate; Device: cellulose acetate with petrolatum; Dichloroacetate; Dichloroacetate sodium; Dirucotide acetate; Edratide acetate; Etiprednol dicloacetate; Experimental glatiramer acetate; Flecainide acetate; Glatiramer acetate; Glatiramer acetate (copaxone®); Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (gtr); Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate [ga]; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Gonadorelin acetate and triptorelin acetate; Human interferon beta-1a and glatiramer acetate; Hydrocortisone acetate; Hydrocortisone sodium acetate; L-lysyl-d-prolyl-l-threonine acetate; L-lysyl-d-prolyl-lthreonine acetate, lyophilisate; Lanreotide acetate; Lapaquistat acetate and current lipid-lowering treatment; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate; Leuprorelin acetate 3.75mg injection; Loestrin (norethindrone acetate and ethinyl estradiol); Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Macimorelin acetate; Megestrol acetate; Megestrol acetate tablet; Methylprednisolone acetate; Nomegestrol acetate; Octreotide acetate; Oxaloacetate (oaa); Phosphate and betamethasone acetate, 2 ml.; Plovamer acetate; Plovamer acetate 0.5 milligram (mg); Plovamer acetate 10 mg; Plovamer acetate 20 mg; Plovamer acetate 3 mg; Prednisolone acetate; Prednisone acetate; Prednisone acetate tablets; Procedure: warm compress prior to injection of glatiramer acetate; Sodium acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Sotrastaurin (inn) acetate; Tetracosactide acetate; Tetracosactide hexaacetate; Tocopherol acetate; Tocopheryl acetate; Triptorelin acetate and gonadorelin acetate; Ulipristal acetate; Zinc acetate; Zinc acetate (20mg/d); Zinc acetate dihydrate; Zuretinol acetate; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; | - |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
6 | Acetohydroxamic acid | Acetohydroxamic acid 2件: Acetohydroxamic acid; Acetohydroxamic acid oral tablet [lithostat]; | 1件: D00220 D00220 💬 |
- |
- |
006 2件: 6 , 251 💬 |
7 | Acetylcysteine | Acetylcysteine 12件: Acetylcysteine; Acetylcysteine effervescent tablets; Acetylcysteine sodium; Fluimucil (acetylcysteine); Glatiramer acetate, n-acetylcysteine; Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets; Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets; N acetylcysteine; N-acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine capsule; N-acetylcysteine, (nac); | 1件: D00221 D00221 💬 |
- |
- |
006 17件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 90, 94, 111, 164, 193, 233, 298, 299 💬 |
8 | ACR325 | Acr325 1件: Acr325; | - |
- |
- |
006 1件: 6 💬 |
9 | Activated charcoal | - | 1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
10 | Ademetionine | - | 1件: D07128 D07128 💬 |
- |
- |
006 2件: 6 , 93 💬 |
11 | Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - |
- |
- |
002 3件: 2 , 6 , 46 💬 |
12 | Agomelatine | Agomelatine 2件: Agomelatine; Agomelatine or piacebo; | 1件: D02578 D02578 💬 |
3件: HTR2C, MTNR1A, MTNR1B 💬 |
Calcium signaling pathway 6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse |
006 1件: 6 💬 |
13 | Alanine | 3-(3,4-dihydroxyphenyl)-l-alanine 7件: 3-(3,4-dihydroxyphenyl)-l-alanine; Alanine; Benzoyl-l-tyrosyl-[1-13c]alanine (bz-tyr-ala); Beta-alanine; Beta-alanine supplementation; L-3-(3,4-dihydroxyphenyl)alanine; L-alanine; | 1件: D00012 D00012 💬 |
- |
- |
006 4件: 6 , 13, 298, 299 💬 |
14 | Albendazole | Albendazole 2件: Albendazole; Albendazole (eskazole); | 1件: D00134 D00134 💬 |
- |
- |
005 11件: 5 , 6 , 7 , 28, 51, 67, 86, 96, 97, 114, 127 💬 |
15 | Allopurinol | Allopurinol 4件: Allopurinol; Allopurinol sandoz 100 mg, tabletten; Allopurinol sodium; Azathioprine and allopurinol; | 1件: D00224 D00224 💬 |
1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 6件: 6 , 46, 57, 66, 96, 97 💬 |
16 | Altropane | Altropane 2件: Altropane; Altropane®; | - |
- |
- |
006 1件: 6 💬 |
17 | Amantadine | 240mg amantadine hcl er tablets 13件: 240mg amantadine hcl er tablets; 320mg amantadine hcl er tablets; Ads-5102 (extended release amantadine hcl); Amantadine; Amantadine 300 mg; Amantadine hcl er; Amantadine hcl extended release; Amantadine hcl extended release capsule; Amantadine hydrochloride; Amantadine hydrochloride (hcl); Amantadine sulfate; Determination of drug effects through amantadine cessation; Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj; | 2件: D00777 D00777
D07441 D07441 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 4件: 6 , 8 , 13, 127 💬 |
18 | Ambroxol | Ambroxol 2件: Ambroxol; Ambroxol hydrochloride; | 1件: D07442 D07442 💬 |
- |
- |
006 2件: 6 , 19 💬 |
19 | Ammonia | 13n-ammonia 4件: 13n-ammonia; Ammonia; Radiation: cardiac pet imaging using f-18-fdg, n-13 ammonia( nh3); Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82; | 1件: D02916 D02916 💬 |
- |
- |
006 4件: 6 , 17, 86, 88 💬 |
20 | Amoxicillin | Amoxicillin 8件: Amoxicillin; Amoxicillin and clavulanic acid; Amoxicillin and tetracycline; Amoxicillin hydrate; Amoxicillin, metronidazole and tetracycline; Clartihromycin, amoxicillin, and omeprazole; Lansoprazole, amoxicillin, clarithromycin; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); | 3件: D00229 D00229
D02925 D02925
D07452 D07452 💬 |
- |
- |
006 9件: 6 , 19, 46, 63, 84, 96, 97, 222, 299 💬 |
21 | Ampicillin | - | 3件: D00204 D00204
D01251 D01251
D02119 D02119 💬 |
- |
- |
002 5件: 2 , 6 , 13, 84, 299 💬 |
22 | Ampreloxetine | Ampreloxetine 3件: Ampreloxetine; Ampreloxetine chydrochloride; Ampreloxetine hydrochloride; | 1件: D11688 D11688 💬 |
2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 17 💬 |
23 | ANX-510 | - | - |
- |
- |
006 3件: 6 , 265, 288 💬 |
24 | Aplindore | Aplindore 2件: Aplindore; Aplindore mr tablets; | - |
- |
- |
006 1件: 6 💬 |
25 | Apomorphine | 6abeta - apomorphine-10,11-diol hydrochloride hemihydrate 21件: 6abeta - apomorphine-10,11-diol hydrochloride hemihydrate; 6aß - apomorphine-10,11-diol hydrochloride hemihydrate; Apomorphine; Apomorphine 0.25% (2.5mg/ml); Apomorphine hcl injection; Apomorphine hydrochloride; Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed; Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed; Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed; Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed; Apomorphine hydrochloride hemihydrate; Apomorphine hydrocloride; Apomorphine hydrocloride hemihydrate; Apomorphine infusion; Apomorphine nasal powder; Continuous apomorphine infusion; Dopaminergic agonist + apomorphine; Injection of apomorphine; Iv apomorphine; S.c. apomorphine; Subcutaneous apomorphine; | 2件: D02004 D02004
D07460 D07460 💬 |
2件: DRD1, DRD2 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
26 | Aripiprazole | Aripiprazole 1件: Aripiprazole; | 1件: D01164 D01164 💬 |
4件: DRD2, DRD3, HTR1A, HTR2A 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 2件: 6 , 206 💬 |
27 | Armodafinil | Armodafinil 1件: Armodafinil; | 1件: D03215 D03215 💬 |
1件: SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 3件: 6 , 13, 84 💬 |
28 | Aspartame | - | 1件: D02381 D02381 💬 |
2件: TAS1R2, TAS1R3 💬 |
Carbohydrate digestion and absorption 2件: Carbohydrate digestion and absorption, Taste transduction |
006 5件: 6 , 13, 67, 86, 230 💬 |
29 | Atomoxetine | Atomoxetine 1件: Atomoxetine; | 2件: D02574 D02574
D07473 D07473 💬 |
1件: SLC6A2 💬 |
Synaptic vesicle cycle 1件: Synaptic vesicle cycle |
006 3件: 6 , 8 , 13 💬 |
30 | AV-101 | Av-101 1件: Av-101; | - |
- |
- |
006 1件: 6 💬 |
31 | Azathioprine | Azathioprine 38件: Azathioprine; Azathioprine (aza); Azathioprine (aza) caps; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine (imuran) 50 mg overencapsulated tablet; Azathioprine - ratiopharm 50 mg; Azathioprine / 6 mercaptopurine; Azathioprine 25 mg; Azathioprine and allopurinol; Azathioprine in case of endoscopic recurrence; Azathioprine individualised dose; Azathioprine or 6-mercaptopurine; Azathioprine or adalimumab and infliximab; Azathioprine or mesalazine; Azathioprine or methotrexate; Azathioprine or mycophenolate mofetil; Azathioprine weight-based dose; Azathioprine+enteral nutrition; Azathioprine/prednisone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Continuation of azathioprine; Corticosteroid and azathioprine; Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide-prednisone-azathioprine; Early immunosuppressants (azathioprine, methotrexate); Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, azathioprine; Overencapsulated azathioprine (imuran) 50 mg tablet; Prednisone - azathioprine; Products containing azathioprine or 6-mercaptopurine; Rituximab (rtx) and azathioprine (aza); Steroids plus azathioprine; Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil); | 2件: D00238 D00238
D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
32 | Bavisant | Bavisant 3件: Bavisant; Bavisant dihydrochloride monohydrate; Bavisant hydrochloride monohydrate; | 1件: D09870 D09870 💬 |
1件: HRH3 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 1件: 6 💬 |
33 | Benserazide | Benserazide 8件: Benserazide; Benserazide hydrochloride; Levodopa / benserazide 200 + 50 mg; Levodopa 100 mg / benserazide 25 mg; Levodopa benserazide madopar; Levodopa benserazide teva italia; Levodopa/benserazide; Levodopa/benserazide 100/25 mg; | 1件: D03082 D03082 💬 |
1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
34 | Benzofuran | Benzofuran 2件: Benzofuran; R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride; | - |
- |
- |
006 1件: 6 💬 |
35 | BIA | 200 mg bia 6-512 26件: 200 mg bia 6-512; 25 mg bia9 1067; 50 mg bia 9 1067; Bia; Bia 3-202; Bia 3-202 (200 mg); Bia 5-1058; Bia 6-512; Bia 6-512 100 mg; Bia 6-512 100 mg dose; Bia 6-512 200 mg dose; Bia 6-512 25 mg; Bia 6-512 25 mg dose; Bia 6-512 400 mg; Bia 6-512 50 mg dose; Bia 9-1067; Bia 9-1067 (test); Bia 9-1067 15 mg; Bia 9-1067 25 mg; Bia 9-1067 30 mg; Bia 9-1067 5 mg; Bia 9-1067 micronized; Bia 9-1067 non-micronized; Bia-5-1058; Other: tampa kinesiophobia scale, berg-balance test, international physical activity questionnaire-short form, falls efficacy scale; [14c]-bia 9-1067; | - |
- |
- |
006 2件: 6 , 86 💬 |
36 | Bifenthrin | - | - |
- |
- |
006 2件: 6 , 46 💬 |
37 | Botulinum toxin type A | Botulinum toxin type a 6件: Botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle; Botulinum toxin type a 200u; Botulinum toxin type a 300u; Botulinum toxin type a infiltrations; Clostridium botulinum toxin type a; | 1件: D00783 D00783 💬 |
1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 13件: 2 , 5 , 6 , 7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬 |
38 | Botulinum Toxin Type B | Botulinum toxin type b 3件: Botulinum toxin type b; Botulinum toxin type b (2500 units / vial); Botulinum toxin type b (myobloc); | 1件: D02735 D02735 💬 |
1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 3件: 2 , 6 , 51 💬 |
39 | Bromocriptine | Bromocriptine 2件: Bromocriptine; Bromocriptine and other dopamine agonists; | 2件: D00780 D00780
D03165 D03165 💬 |
2件: DRD2, PRL 💬 |
Alcoholism 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 2件: 6 , 74 💬 |
40 | BTRX-246040 | Btrx-246040 1件: Btrx-246040; | - |
- |
- |
006 1件: 6 💬 |
41 | Bumetanide | Bumetanide 2件: Bumetanide; Bumetanide white, oblong, scored tablet; | 1件: D00247 D00247 💬 |
1件: SLC12A2 💬 |
Pancreatic secretion 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection |
006 2件: 6 , 158 💬 |
42 | Buspirone | Buspirone 2件: Buspirone; Buspirone hydrochloride; | 2件: D00702 D00702
D07593 D07593 💬 |
2件: DRD2, HTR1A 💬 |
Alcoholism 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 2件: 6 , 51 💬 |
43 | Butylphthalide | Butylphthalide 2件: Butylphthalide; Dl-3-n-butylphthalide (nbp); | - |
- |
- |
002 4件: 2 , 6 , 18, 22 💬 |
44 | Cabergoline | Cabergoline 3件: Cabergoline; Cabergoline teva; Pasireotide with or without cabergoline; | 1件: D00987 D00987 💬 |
2件: DRD2, PRL 💬 |
Alcoholism 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 3件: 6 , 74, 75 💬 |
45 | Caffeine | Caffeine 6件: Caffeine; Caffeine 100 mg; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Other: caffeine; | 2件: D00528 D00528
D01453 D01453 💬 |
11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
46 | Calcium | Amorphous calcium carbonate 34件: Amorphous calcium carbonate; Ascal(r) / carbasalate calcium; Atorvastatin calcium; Calcitriol & calcium; Calcium; Calcium and cholecalciferol; Calcium and vitamin d combination; Calcium carbonate; Calcium carbonate and alphacalcidol; Calcium carbonate d; Calcium channel blockers; Calcium citrate; Calcium citrate with vitamin d2; Calcium gluconate; Calcium lactate; Calcium levofolinate; Calcium rosuvastatin; Calcium, dietary; Carbasalate calcium; Crestor tablets (calcium rosuvastatin) film-coated tablets; Crystalline calcium supplements; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Low molecular weight heparin calcium injection; Other: calcium stable isotope; Other: determination of calcium intake by a dietician interview; Other: empiric use of calcium carbonate and calcitriol; Other: pth based calcium carbonate and calcitriol repletion; Other: serum calcium concentrations results; Rosuvastatin calcium; Rosuvastatin calcium 40mg; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Vidofludimus calcium; Vidofludimus calcium dihydrate; | - |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
47 | Cannabidiol | Avcn583601 (3% cannabidiol cream) 11件: Avcn583601 (3% cannabidiol cream); Cannabidiol; Cannabidiol (cbd); Cannabidiol , synthetic form; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol botanical drug substance (cbd bds); Cannabidiol capsule 5 mg; Cannabidiol oral solution; Cannabidiol tablet 10 mg; Cannabidiol vaginal suppository; Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd); | 1件: D10915 D10915 💬 |
2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 19件: 2 , 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
48 | Capsaicin | Capsaicin 5件: Capsaicin; Capsaicin challenge; Capsaicin vapor; Other: challenge agent: capsaicin; Qutenza (8% capsaicin); | 1件: D00250 D00250 💬 |
1件: TRPV1 💬 |
Inflammatory mediator regulation of TRP channels 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 5件: 2 , 6 , 19, 86, 226 💬 |
49 | Captopril | Captopril 2件: Captopril; Spironolactone captopril carvedilol; | 1件: D00251 D00251 💬 |
1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
006 8件: 6 , 17, 46, 86, 96, 97, 107, 271 💬 |
50 | Carbidopa | Accordion pill carbidopa/levodopa 85件: Accordion pill carbidopa/levodopa; Accordion pill ¿ carbidopa/levodopa 50/400 mg; Accordion pill ¿ carbidopa/levodopa 50/500 mg; Accordion pill? carbidopa/levodopa 50/400 mg; Accordion pill? carbidopa/levodopa 50/500 mg; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Anhydrous carbidopa; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa; Carbidopa (fu); Carbidopa 20 mg; Carbidopa 200mg oral dose; Carbidopa 27.5 mg; Carbidopa 65 mg capsule; Carbidopa and levodopa 25mg/100mg; Carbidopa and levodopa tablets, usp; Carbidopa anidra; Carbidopa fu; Carbidopa inn; Carbidopa levodopa; Carbidopa monohydrate; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa-4'-monophosphate; Carbidopa-levodopa; Carbidopa-levodopa 25 mg-100 mg oral tablet; Carbidopa/l-dopa; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Carbidopamonohydraat; Combination product: l-dopa 70mg/carbidopa 7mg; Comparator: carbidopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel; Entacapone and carbidopa; Foscarbidopa; Foscarbidopa and foslevodopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 10/100 mg; Immediate release carbidopa/levodopa 25/100 mg; Ir cd-ld (carbidopa-levodopa) tablets; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa intestinal gel (lcig); Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/carbidopa; Levodopa/carbidopa (4:1); Levodopa/carbidopa (ld/cd); Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Nd0612 (levodopa/carbidopa solution); Odm-101 105mg carbidopa; Odm-101 65mg carbidopa; Oral levodopa and carbidopa; Oral levodopa/carbidopa; Sinemet (carbidopa/levodopa); Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Stalevo (levodopa/carbidopa/entacapone); Wd-1603 carbidopa and levodopa extended-release tablets; Wd-1603 carbidopa/levodopa extended-release tablets; Xp21279 and carbidopa (experimental); | 1件: D00558 D00558 💬 |
1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
51 | Carbon monoxide | Carbon monoxide 3件: Carbon monoxide; Inhaled carbon monoxide; Other: carbon monoxide-bubbled mediums; | 1件: D09706 D09706 💬 |
- |
- |
006 7件: 6 , 13, 53, 70, 85, 86, 298 💬 |
52 | Carnosine | Carnosine 3件: Carnosine; Carnosine supplementation; Carnosine, capsulle, 2 g/day, 8 weeks; | - |
- |
- |
006 2件: 6 , 13 💬 |
53 | Carvedilol | Carvedilol 2件: Carvedilol; Spironolactone captopril carvedilol; | 2件: D00255 D00255
D03415 D03415 💬 |
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 |
AMPK signaling pathway 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 5件: 6 , 57, 86, 113, 210 💬 |
54 | Ceftriaxone | Ceftriaxone 1件: Ceftriaxone; | 2件: D00924 D00924
D07659 D07659 💬 |
- |
- |
002 3件: 2 , 6 , 97 💬 |
55 | CEP-1347 | Cep-1347 5件: Cep-1347; Cep-1347 10mg; Cep-1347 50mg; Cep1347; Cep1347 25mg; | - |
- |
- |
006 1件: 6 💬 |
56 | Chloride ion | - | - |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
57 | Cholecalciferol | 5000 iu of cholecalciferol 11件: 5000 iu of cholecalciferol; Calcium and cholecalciferol; Cholecalciferol; Cholecalciferol (vitamin d3); Cholecalciferol (vitamind3); Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol and c. xanthorrhiza; Cholecalciferol concentrate; Cholecalciferol concentrate (water-dispersible form); Cholecalciferol, vitamin d3; | 1件: D00188 D00188 💬 |
1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 23件: 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬 |
58 | Citalopram | 20mg daily citalopram 8件: 20mg daily citalopram; Bupropion & citalopram; Citalopram; Citalopram 20mg; Escitalopram; Escitalopram oxalate; Escitalopram oxalate antidepressant; Oral escitalopram; | 2件: D00822 D00822
D07704 D07704 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 6件: 6 , 8 , 13, 18, 46, 127 💬 |
59 | Clarithromycin | A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine 8件: A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine; Biaxin ( clarithromycin); Clarithromycin; Clarithromycin (not used as of 4/2020); Lansoprazole, amoxicillin, clarithromycin; Lansoprazole, clarithromycin, amoxycillin; Rifabutin, clarithromycin, and clofazimine; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); | 1件: D00276 D00276 💬 |
- |
- |
006 8件: 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
60 | Clenbuterol | Clenbuterol 3件: Clenbuterol; Clenbuterol hcl; Clenbuterol hydrochloride; | 1件: D07713 D07713 💬 |
1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
001 5件: 1 , 2 , 6 , 13, 256 💬 |
61 | Clonazepam | Clonazepam 1件: Clonazepam; | 1件: D00280 D00280 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 1件: 6 💬 |
62 | Clonidine | Clonidine 5件: Clonidine; Clonidine hcl cf 0,150 mg, tabletten; Clonidine hydrochloride; Device: clonidine (catapressan); Procedure: arginine and clonidine stimulation testing; | 2件: D00281 D00281
D00604 D00604 💬 |
3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 2件: 6 , 78 💬 |
63 | Clozapine | Clozapine 1件: Clozapine; | 1件: D00283 D00283 💬 |
11件: ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Calcium signaling pathway 8件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
64 | Cobalt chloride | - | - |
- |
- |
006 1件: 6 💬 |
65 | Cocoa | Cocoa 3件: Cocoa; Dark chocolate (85% cocoa); White chocolate (0% cocoa); | - |
- |
- |
006 1件: 6 💬 |
66 | Creatine | Creatine 4件: Creatine; Creatine monohydrate; Creatine-13c; Pyruvate, creatine, niacinamide; | - |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
67 | Cyanocobalamin | - | 4件: D00166 D00166
D03615 D03615
D03616 D03616
D03617 D03617 💬 |
- |
- |
006 5件: 6 , 13, 201, 229, 299 💬 |
68 | Cycloserine | - | 1件: D00877 D00877 💬 |
- |
- |
006 1件: 6 💬 |
69 | Cysteine | Acetylcysteine 17件: Acetylcysteine; Acetylcysteine effervescent tablets; Cysteine; Cysteine hydrochloride; Glatiramer acetate, n-acetylcysteine; Intravenous and oral n-acetyl cysteine; Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets; Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets; N acetyl cysteine; N acetylcysteine; N-acetyl cysteine; N-acetyl cysteine (nac); N-acetyl-cysteine; N-acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine capsule; N-acetylcysteine, (nac); | 2件: D00026 D00026
D02326 D02326 💬 |
- |
- |
006 11件: 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
70 | D-Serine | D-serine 2件: D-serine; D-serine (~2g/day); | - |
- |
- |
006 1件: 6 💬 |
71 | Dalfampridine | Dalfampridine 6件: Dalfampridine; Dalfampridine er; Dalfampridine-er 10mg; Dalfampridine-er 5mg; Other: withdrawal of dalfampridine-er 10mg; Sustained-release oral dalfampridine; | 1件: D04127 D04127 💬 |
4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 5件: 3 , 4 , 6 , 13, 14 💬 |
72 | Darifenacin | Darifenacin 3件: Darifenacin; Darifenacin (bay79-4998); Oxybutynin and darifenacin; | 2件: D01699 D01699
D03654 D03654 💬 |
1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 2件: 6 , 13 💬 |
73 | Deanol | Deanol 2件: Deanol; Deanol pyroglutamate; | 1件: D07777 D07777 💬 |
- |
- |
006 1件: 6 💬 |
74 | Deferiprone | Deferiprone 11件: Deferiprone; Deferiprone (ferriprox); Deferiprone 20mg; Deferiprone 30mg; Deferiprone 600 mg delayed release tablet; Deferiprone 80 mg/ml oral solution; Deferiprone 80 mg/ml oral solution (ferriprox); Deferiprone dr; Deferiprone oral solution; Deferiprone treated; Ferrprox (deferiprone); | 1件: D07416 D07416 💬 |
- |
- |
002 6件: 2 , 6 , 18, 120, 122, 233 💬 |
75 | Delorazepam | - | 1件: D07784 D07784 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 3件: 6 , 46, 97 💬 |
76 | Desipramine | Administration of a high dose of desipramine 4件: Administration of a high dose of desipramine; Administration of a low dose of desipramine; Desipramine; Desipramine (dmi); | 2件: D00812 D00812
D07791 D07791 💬 |
2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 4件: 6 , 17, 120, 156 💬 |
77 | Desmopressin | Ddavp (desmopressin) 9件: Ddavp (desmopressin); Desmopressin; Desmopressin acetat; Desmopressin acetate; Desmopressin acetate trihydrate; Desmopressin intranasal; Desmopressin oral melt; Desmopressine; Desmopressine nasal spray 10 mg/ml, flacon 60 doses; | 2件: D00291 D00291
D02235 D02235 💬 |
2件: AVPR2, F8 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
006 6件: 6 , 64, 72, 75, 225, 288 💬 |
78 | Dexmedetomidine | Dexmedetomidine 10件: Dexmedetomidine; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3; Dexmedetomidine group; Dexmedetomidine hydrochloride; Dexmedetomidine hydrochloride infusion; Dexmedetomidine with ropivacaine; Fentanyl (low dose) + dexmedetomidine; Scopolamine, atropine, edaravone and dexmedetomidine; | 2件: D00514 D00514
D01205 D01205 💬 |
3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 12件: 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
79 | Dextromethorphan | Dextromethorphan 10件: Dextromethorphan; Dextromethorphan 30 mg; Dextromethorphan and caffeine; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; | 3件: D00848 D00848
D03742 D03742
D03744 D03744 💬 |
6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
80 | Dextrose, unspecified form | - | - |
- |
- |
002 18件: 2 , 6 , 13, 49, 50, 56, 60, 65, 70, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
81 | Dichloroisoproterenol | - | - |
- |
- |
006 2件: 6 , 299 💬 |
82 | Dihydrotachysterol | - | 1件: D00299 D00299 💬 |
1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 1件: 6 💬 |
83 | Dipivefrin | Dipivefrin 2件: Dipivefrin; Dipivefrine; | 1件: D02349 D02349 💬 |
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
84 | Dipraglurant | Dipraglurant 1件: Dipraglurant; | - |
- |
- |
006 1件: 6 💬 |
85 | Doconexent | - | - |
- |
- |
006 10件: 6 , 46, 48, 49, 90, 94, 113, 240, 299, 301 💬 |
86 | Domperidone | Domperidone 3件: Domperidone; Domperidone (drug); Levodopa and domperidone; | 2件: D01745 D01745
D07868 D07868 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 5件: 6 , 13, 17, 51, 230 💬 |
87 | Donepezil | Donepezil 7件: Donepezil; Donepezil hci (drug); Donepezil hydrochloride; Donepezil sandoz; Other: [11c]donepezil pet; Pridia (donepezil hydrochloride) 5mg; Prior donepezil 5mg; | 2件: D00670 D00670
D07869 D07869 💬 |
1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 9件: 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
88 | Dopamine | A-dopamine 16件: A-dopamine; Behavioral: assessment of motor and non-motors symptoms of pd evaluation of hyper- and hypodopaminergic behaviors; Behavioral: role of dopamine; Bromocriptine and other dopamine agonists; Cerebral dopamine neurotrophic factor; Continuous release dopamine agonists; Dopamine; Dopamine agent; Dopamine agonist treatment; Dopamine agonists; Dopamine agonists (pramipexole, ropirinole); Dopaminergic agonist + apomorphine; Dopaminergic agonists; Procedure: embryonic dopamine cell implant surgery; Recombinant human cerebral dopamine neurotrophic factor; Usual dopaminergic per os treatment; | 2件: D00633 D00633
D07870 D07870 💬 |
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 3件: 6 , 7 , 74 💬 |
89 | Doxepin | Doxepin 2件: Doxepin; Doxepin and zopiclone; | 2件: D00814 D00814
D07875 D07875 💬 |
3件: HRH1, SLC6A2, SLC6A4 💬 |
Calcium signaling pathway 5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
006 1件: 6 💬 |
90 | Droxidopa | Droxidopa 2件: Droxidopa; Droxidopa 100 mg [northera]; | 1件: D01277 D01277 💬 |
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
005 3件: 5 , 6 , 17 💬 |
91 | Duloxetine | Duloxetine 3件: Duloxetine; Duloxetine hydrochloride; Duloxetine hydrochloride (hci); | 2件: D01179 D01179
D07880 D07880 💬 |
2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 13 💬 |
92 | Eliprodil | Eliprodil 1件: Eliprodil; | - |
- |
- |
006 1件: 6 💬 |
93 | Elobixibat | Elobixibat 1件: Elobixibat; | 1件: D10796 D10796 💬 |
1件: SLC10A2 💬 |
Bile secretion 1件: Bile secretion |
006 1件: 6 💬 |
94 | Eltoprazine | Eltoprazine 3件: Eltoprazine; Eltoprazine hcl; Eltoprazine hydrochloride; | - |
- |
- |
006 1件: 6 💬 |
95 | Entacapone | Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) 15件: Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa, levodopa, entacapone; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa/entacapone; Entacapone; Entacapone 400mg oral dose; Entacapone and carbidopa; Entacapone inn; Levodopa, carbidopa, entacapone; Levodopa-carbidopa-entacapone; Levodopa/carbidopa/entacapone; Over-encapsulated entacapone tablets; Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapone); V1512 and entacapone; | 1件: D00781 D00781 💬 |
1件: COMT 💬 |
Dopaminergic synapse 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
96 | EPI-589 | Epi-589 1件: Epi-589; | - |
- |
- |
002 2件: 2 , 6 💬 |
97 | Epigallocatechin gallate | Coconut oil and epigallocatechin gallate 2件: Coconut oil and epigallocatechin gallate; Epigallocatechin gallate; | - |
- |
- |
006 9件: 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
98 | Ergoloid mesylate | - | 1件: D02268 D02268 💬 |
6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
99 | Erythromycin | Erythromycin 3件: Erythromycin; Erythromycine; Oral erythromycin; | 9件: D00140 D00140
D00851 D00851
D01361 D01361
D02009 D02009
D02184 D02184
D02523 D02523
D02524 D02524
D02525 D02525
D04054 D04054 💬 |
- |
- |
006 5件: 6 , 36, 164, 228, 291 💬 |
100 | Erythropoietin | Erythropoietin 4件: Erythropoietin; Erythropoietin human recombinant (eporh); Recombinant human erythropoietin; Recombinant human erythropoietin(rhepo); | 1件: D03231 D03231 💬 |
1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 10件: 2 , 6 , 13, 18, 22, 46, 47, 70, 95, 96 💬 |
101 | Escitalopram | Escitalopram 4件: Escitalopram; Escitalopram oxalate; Escitalopram oxalate antidepressant; Oral escitalopram; | 3件: D02567 D02567
D07704 D07704
D07913 D07913 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
002 3件: 2 , 6 , 13 💬 |
102 | Eszopiclone | Eszopiclone 1件: Eszopiclone; | 1件: D02624 D02624 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 3件: 6 , 13, 46 💬 |
103 | Exametazime | Exametazime 2件: Exametazime; Technetium (99mtc) exametazime; | 1件: D01109 D01109 💬 |
- |
- |
006 1件: 6 💬 |
104 | Exenatide | Exenatide 5件: Exenatide; Exenatide 10 micrograms; Exenatide 5 micrograms; Exenatide extended release 2mg (bydureon); Exenatide pen injector [bydureon]; | 1件: D04121 D04121 💬 |
1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 4件: 6 , 17, 193, 233 💬 |
105 | Famotidine | Famotidine 2件: Famotidine; Famotidine 20 mg; | 1件: D00318 D00318 💬 |
1件: HRH2 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
006 4件: 6 , 46, 86, 98 💬 |
106 | Febuxostat | Febuxostat 1件: Febuxostat; | 1件: D01206 D01206 💬 |
1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
002 3件: 2 , 6 , 13 💬 |
107 | Fenamole | - | 1件: D04139 D04139 💬 |
- |
- |
006 3件: 6 , 13, 160 💬 |
108 | Fesoterodine | Fesoterodine 1件: Fesoterodine; | 1件: D07226 D07226 💬 |
2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 1件: 6 💬 |
109 | Filgrastim | Ep2006 (filgrastim) 7件: Ep2006 (filgrastim); Filgrastim; Filgrastim (g-csf); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Pegfilgrastim; | 1件: D03235 D03235 💬 |
1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 33件: 2 , 6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
110 | Finasteride | Finasteride 1件: Finasteride; | 1件: D00321 D00321 💬 |
1件: SRD5A2 💬 |
Prostate cancer 2件: Prostate cancer, Steroid hormone biosynthesis |
006 1件: 6 💬 |
111 | Fipamezole | Fipamezole 7件: Fipamezole; Fipamezole hydrochloride; Fipamezole hydrochloride 30 mg oral disintegrating tablets; Fipamezole hydrochloride 60 mg oral disintegrating tablets; Fipamezole hydrochloride 90 mg oral disintegrating tablets; Fipamezole odt; Fipamezole odt cohort 2; | - |
- |
- |
006 2件: 6 , 17 💬 |
112 | Flecainide | Flecainide 2件: Flecainide; Flecainide acetate; | 2件: D00638 D00638
D07962 D07962 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 1件: 6 💬 |
113 | Florbenazine F-18 | - | - |
- |
- |
006 1件: 6 💬 |
114 | Florbetaben (18F) | - | 1件: D10002 D10002 💬 |
- |
- |
006 1件: 6 💬 |
115 | Fludeoxyglucose (18F) | - | - |
- |
- |
005 13件: 5 , 6 , 7 , 13, 34, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
116 | Fludrocortisone | Fludrocortisone 1件: Fludrocortisone; | 2件: D00986 D00986
D07967 D07967 💬 |
1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
006 3件: 6 , 17, 81 💬 |
117 | Flumazenil | 11c-flumazenil 7件: 11c-flumazenil; Diagnostic test: pet with [11c]flumazenil; Flumazenil; Pet with 11c-flumazenil; Transdermal flumazenil (added 4/2020); [11c]flumazenil; [18f]flumazenil; | 1件: D00697 D00697 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 5件: 6 , 13, 17, 18, 206 💬 |
118 | Flutemetamol | Diagnostic test: flutemetamol f18 injection 4件: Diagnostic test: flutemetamol f18 injection; Flutemetamol; Flutemetamol f18; Vizamyl (flutemetamol(f-18)); | - |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
119 | Flutemetamol (18F) | - | 1件: D10231 D10231 💬 |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
120 | Folic acid | Folic acid 5件: Folic acid; Folic acid or folate; Folic acid, vitamin b6, vitamin b12; Methotrexate and folic acid; Rituximab, mtx, folic acid; | 1件: D00070 D00070 💬 |
- |
- |
006 5件: 6 , 13, 46, 49, 84 💬 |
121 | Foliglurax | Foliglurax 3件: Foliglurax; Foliglurax 10 mg (treatment a); Foliglurax 30 mg (treatment b); | - |
- |
- |
006 1件: 6 💬 |
122 | Foscarbidopa | Foscarbidopa 2件: Foscarbidopa; Foscarbidopa and foslevodopa; | - |
- |
- |
006 1件: 6 💬 |
123 | Gabapentin | Gabapentin 9件: Gabapentin; Gabapentin prescriptions; Gabapentina; Gabapentina kern pharma; Gabapentine; Gabapentine 300mg; Multi-modal pain management [acetaminophen + gabapentin]; Multi-modal pain management [valium + gabapentin]; Transdermal fentanyl matrix, gabapentin; | 1件: D00332 D00332 💬 |
5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 5件: 6 , 13, 19, 70, 298 💬 |
124 | Galantamine | Galantamine 2件: Galantamine; Galantamine hydrobromide; | 2件: D02173 D02173
D04292 D04292 💬 |
1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
006 2件: 6 , 127 💬 |
125 | gamma-Hydroxybutyric acid | - | - |
- |
- |
006 2件: 6 , 149 💬 |
126 | Ginkgo biloba | Ginkgo biloba 3件: Ginkgo biloba; Ginkgo biloba pills sig: 300mg/tid; Standardized ginkgo biloba extract (egb 761 (r); | - |
- |
- |
006 4件: 6 , 13, 18, 90 💬 |
127 | Glutathione | Glutathione 11件: Glutathione; Glutathione sodium; Gsh (glutathione); Inhaled reduced glutathione; Intranasal glutathione - (in)gsh; Oral glutathione; Oral reduced l-glutathione; Reduced glutathione; Reduced glutathione 100mg; Reduced glutathione 200mg; Reduced glutathione sodium salt; | 2件: D00014 D00014
D00031 D00031 💬 |
- |
- |
006 2件: 6 , 299 💬 |
128 | Glycerin | Glycerine 2件: Glycerine; Other: glycerine gel; | 1件: D00028 D00028 💬 |
- |
- |
006 6件: 6 , 13, 79, 265, 316, 317 💬 |
129 | Glycerol phenylbutyrate | Glycerol phenylbutyrate 1件: Glycerol phenylbutyrate; | 1件: D10127 D10127 💬 |
- |
- |
006 3件: 6 , 251, 299 💬 |
130 | Gold | Gold 7件: Gold; Gold nanocrystals; Mtx goldshield tablets; Other: comparator: cpet cycle ergometer (gold standard); Procedure: quantiferon-tb gold assay; Procedure: repair of cdh w/sis gold; Sodium aurothiomalate (intramuscular gold); | - |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
131 | GPI-1485 | Gpi 1485 1件: Gpi 1485; | - |
- |
- |
006 1件: 6 💬 |
132 | Grapefruit | Grapefruit 2件: Grapefruit; Grapefruit juice; | - |
- |
- |
006 5件: 6 , 46, 50, 83, 97 💬 |
133 | Green tea leaf | Green tea leaf 1件: Green tea leaf; | 1件: D06903 D06903 💬 |
- |
- |
006 5件: 6 , 17, 28, 46, 96 💬 |
134 | Guar gum | Guar gum 2件: Guar gum; Hydrolyzed guar gum; | 1件: D04403 D04403 💬 |
- |
- |
006 1件: 6 💬 |
135 | Heptaminol | Heptaminol 2件: Heptaminol; Heptaminol hydrochloride; | 1件: D07158 D07158 💬 |
- |
- |
006 1件: 6 💬 |
136 | Hydrocortisone | 90 mg hydrocortisone acetate suppository with sephure suppository applicator 31件: 90 mg hydrocortisone acetate suppository with sephure suppository applicator; Combination oral budesonide and rectal hydrocortisone; Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortef (hydrocortisone); Dual release hydrocortisone (plenadren); Hydrocortisone; Hydrocortisone (solucortef); Hydrocortisone 100mg/ml; Hydrocortisone 10mg; Hydrocortisone 10mg tablet; Hydrocortisone 10mg tablets; Hydrocortisone 20mg tablets; Hydrocortisone acetate; Hydrocortisone cream; Hydrocortisone cream 1%; Hydrocortisone cream 10mg/g fna fagron; Hydrocortisone hydrogen succinate; Hydrocortisone modified release capsules; Hydrocortisone roussel; Hydrocortisone sodium acetate; Hydrocortisone sodium phosphate; Hydrocortisone sodium succinate; Hydrocortisone tablet 2.5 mg; Hydrocortisone takeda, tabletter; Mesalazine with hydrocortisone sodium succinate; Other: hydrocortisone; Procedure: hydrocortisone withdrawal; Solu-cortef (hydrocortisone); Subcutaneous hydrocortisone; Subcutaneous hydrocortisone 10mg; | 1件: D00088 D00088 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 9件: 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
137 | Hydrocortisone cypionate | - | 1件: D00976 D00976 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 3件: 6 , 81, 83 💬 |
138 | Hydrocortisone succinate | - | 1件: D01442 D01442 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 3件: 6 , 81, 83 💬 |
139 | Hydrogen | 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate 8件: 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate; Hydrocortisone hydrogen succinate; Hydrogen; Hydrogen peroxide; Lisuride hydrogenmaleate; Methylprednisolon-21-hydrogensuccinat, natriumsalz; Other: hydrogen peroxide; Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt); | - |
- |
- |
005 7件: 5 , 6 , 13, 17, 83, 97, 226 💬 |
140 | Idebenone | Idebenone 2件: Idebenone; Idebenone 150 mg film-coated tablets; | 1件: D01750 D01750 💬 |
- |
- |
006 5件: 6 , 13, 18, 113, 302 💬 |
141 | Inosine | 1) inosine 5'-monophosphate 2件: 1) inosine 5'-monophosphate; Inosine; | 1件: D00054 D00054 💬 |
- |
- |
002 5件: 2 , 6 , 13, 17, 85 💬 |
142 | Iodide I-123 | - | - |
- |
- |
002 2件: 2 , 6 💬 |
143 | Ioflupane I-123 | - | 1件: D10014 D10014 💬 |
- |
- |
002 4件: 2 , 5 , 6 , 17 💬 |
144 | Ipratropium | Bromure d'ipratropium 5件: Bromure d'ipratropium; Ipratropium; Ipratropium bromide (drug); Nebulized combination ipratropium bromide with salbutamol; Nebulized ipratropium bromide; | 1件: D02212 D02212 💬 |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 2件: 6 , 86 💬 |
145 | Iproniazid | Iproniazid 1件: Iproniazid; | 1件: D02579 D02579 💬 |
2件: MAOA, MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
146 | Isoflurane | Isoflurane 1件: Isoflurane; | 1件: D00545 D00545 💬 |
- |
- |
006 1件: 6 💬 |
147 | Isoxaflutole | - | - |
- |
- |
005 9件: 5 , 6 , 13, 46, 81, 113, 122, 149, 299 💬 |
148 | Isradipine | Dynacirc cr (isradipine) 5件: Dynacirc cr (isradipine); Isradipine; Isradipine cr 10mg; Isradipine cr 20mg; Isradipine cr 5mg; | 1件: D00349 D00349 💬 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
149 | Istradefylline | Istradefylline 8件: Istradefylline; Istradefylline ( kw-6002); Istradefylline (kw-6002); Istradefylline 20 mg; Istradefylline 20 mg or 40 mg; Istradefylline 40 mg; Kw-6002 (istradefylline); Rifampin 300mg bid + istradefylline 40mg day 8 only; | 1件: D04641 D04641 💬 |
1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
150 | ITI-214 | Iti-214 1件: Iti-214; | - |
- |
- |
006 1件: 6 💬 |
151 | Josamycin | - | 1件: D01235 D01235 💬 |
- |
- |
006 2件: 6 , 13 💬 |
152 | Ketamine | Esketamine 6件: Esketamine; Esketamine hydrochloride; Ketamine; Multi-modal pain management [intravenous ketamine]; S-ketamine; S-ketamine & midazolam; | 2件: D00711 D00711
D08098 D08098 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 8件: 2 , 4 , 6 , 13, 70, 113, 156, 215 💬 |
153 | Lactobacillus plantarum | Daily ingestion of lactobacillus plantarum ps128 4件: Daily ingestion of lactobacillus plantarum ps128; Lactobacillus plantarum; Lactobacillus plantarum ps128; Probiotic-lactobacillus plantarum ps128; | - |
- |
- |
006 3件: 6 , 97, 156 💬 |
154 | Lactose | 2'-fucosyllactose 4件: 2'-fucosyllactose; Lactose; Lactose in water; Lactose monohydrate; | 2件: D00046 D00046
D03226 D03226 💬 |
- |
- |
002 6件: 2 , 6 , 13, 97, 228, 310 💬 |
155 | Lenomorelin | - | - |
- |
- |
006 3件: 6 , 78, 299 💬 |
156 | Leptin | Hu leptin (a-100) 5件: Hu leptin (a-100); Human recombinant leptin (metreleptin); Leptin; Metreleptin; R-methuleptin; | - |
- |
- |
006 2件: 6 , 265 💬 |
157 | Leucine | Administration of stable isotope-labelled leucine- 8件: Administration of stable isotope-labelled leucine-; Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels; Essential amino acid intake + leucine vs total aa supplement; L-leucine; Leucine; N acetyl l leucine; N-acetyl-l-leucine; Other: 13c6 leucine; | 1件: D00030 D00030 💬 |
- |
- |
005 10件: 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
158 | Levetiracetam | Levetiracetam 1件: Levetiracetam; | 1件: D00709 D00709 💬 |
1件: SV2A 💬 |
ECM-receptor interaction 1件: ECM-receptor interaction |
002 4件: 2 , 4 , 6 , 13 💬 |
159 | Levodopa | Accordion pill carbidopa/levodopa 111件: Accordion pill carbidopa/levodopa; Accordion pill ¿ carbidopa/levodopa 50/400 mg; Accordion pill ¿ carbidopa/levodopa 50/500 mg; Accordion pill? carbidopa/levodopa 50/400 mg; Accordion pill? carbidopa/levodopa 50/500 mg; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Behavioral: levodopa or acupuncture; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa and levodopa 25mg/100mg; Carbidopa and levodopa tablets, usp; Carbidopa levodopa; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa-levodopa; Carbidopa-levodopa 25 mg-100 mg oral tablet; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Comparator: levodopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel; Foscarbidopa and foslevodopa; Foslevodopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 10/100 mg; Immediate release carbidopa/levodopa 25/100 mg; Intravenous levodopa; Ir cd-ld (carbidopa-levodopa) tablets; Iv levodopa; Levodopa; Levodopa (dc.it) (fu); Levodopa (delivered intravenously); Levodopa (drug), intraduodenal administration; Levodopa (l-dopa); Levodopa (l-dopa) + standard care; Levodopa / benserazid; Levodopa / benserazide 200 + 50 mg; Levodopa 100 mg / benserazide 25 mg; Levodopa 100 mg a cap; Levodopa 125 mg a cap; Levodopa 150 mg a cap; Levodopa 25mg/100mg; Levodopa 75 mg a cap; Levodopa acute challenge; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa and decarboxylase inhibitor; Levodopa and domperidone; Levodopa benserazide madopar; Levodopa benserazide teva italia; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa cr (controlled release); Levodopa cyclops; Levodopa dc.it fu; Levodopa dispersible; Levodopa infusion; Levodopa inn; Levodopa mr; Levodopa powder for inhalation; Levodopa tablet; Levodopa test; Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa, decarboxylase inhibitor and comt inhibitor; Levodopa-4'-monophosphate; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa intestinal gel (lcig); Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/benserazide; Levodopa/benserazide 100/25 mg; Levodopa/benzeraside; Levodopa/benzerazide; Levodopa/carbidopa; Levodopa/carbidopa (4:1); Levodopa/carbidopa (ld/cd); Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Levodopa/ddci; Levodopa/dopa decarboxylase inhibitor; Melevodopa; Melevodopa and decarboxylase inhibitor; Nacom levodopa+cardidopa; Nd0612 (levodopa/carbidopa solution); Oral levodopa and carbidopa; Oral levodopa/carbidopa; Rasagiline mesylate with levodopa; Safinamide + levodopa; Sinemet (carbidopa/levodopa); Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Stalevo (levodopa/carbidopa/entacapone); Tvp-1012 (1 mg/day) with levodopa; Wd-1603 carbidopa and levodopa extended-release tablets; Wd-1603 carbidopa/levodopa extended-release tablets; | 1件: D00059 D00059 💬 |
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
160 | Levomefolic acid | - | 1件: D09353 D09353 💬 |
- |
- |
006 1件: 6 💬 |
161 | Liatermin | Liatermin 2件: Liatermin; Liatermin (r-methugdnf); | 1件: D04727 D04727 💬 |
- |
- |
006 1件: 6 💬 |
162 | Lidocaine | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream 11件: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream; Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Heparin & alkalinized lidocaine bladder instillation; Lidocaine; Lidocaine 1% injectable solution; Lidocaine 2% without vessel constrictor; Lidocaine injection 2%; Lidocaine patch 5%; Lidocaine releasing intravesical system - liris®; Local anesthesia (lidocaine hydrochloride); | 3件: D00358 D00358
D02086 D02086
D08127 D08127 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 12件: 6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬 |
163 | Linoleic acid | Linoleic acid 3件: Linoleic acid; Linoleic acid supplementation; Linoleic acid/oleic acid; | - |
- |
- |
006 6件: 6 , 13, 75, 76, 222, 299 💬 |
164 | Liraglutide | Liraglutide 1件: Liraglutide; | 1件: D06404 D06404 💬 |
1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 3件: 6 , 75, 193 💬 |
165 | Lisuride | Continuous subcutaneous lisuride infusion 8件: Continuous subcutaneous lisuride infusion; Lisuride; Lisuride hydrogenmaleate; Lisuride transdermal system; Lisuride tts; Lisuride tts 10cm²; Lisuride tts 20cm²; Transdihydrolisuride; | 2件: D01462 D01462
D08132 D08132 💬 |
3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 2件: 6 , 86 💬 |
166 | Lithium citrate | Lithium citrate 1件: Lithium citrate; | 1件: D04749 D04749 💬 |
- |
- |
002 5件: 2 , 5 , 6 , 7 , 8 💬 |
167 | Lixisenatide | Lixisenatide 1件: Lixisenatide; | 1件: D09729 D09729 💬 |
1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 1件: 6 💬 |
168 | Lovastatin | Lovastatin 5件: Lovastatin; Lovastatin 60 mg; Lovastatin ™; Lovastatin, then minocycline/lovastatin; Minocycline, then minocycline/lovastatin; | 1件: D00359 D00359 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬 |
169 | Lubiprostone | Lubiprostone 1件: Lubiprostone; | 1件: D04790 D04790 💬 |
1件: CLCN2 💬 |
Mineral absorption 1件: Mineral absorption |
006 4件: 6 , 13, 290, 299 💬 |
170 | Magnesium | (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide 19件: (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; (s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; Magnesium; Magnesium aspartate; Magnesium aspartate hydrochloride; Magnesium citrate; Magnesium gluconate; Magnesium hydroxide; Magnesium oxide; Magnesium sulfate; Magnesium with ropivacaine; Mineral boost (magnesium); Nexium (esomeprazole magnesium); Omeprazole magnesium; Saroglitazar magnesium 2 mg; Saroglitazar magnesium 4 mg; Sodium picosulfate, magnesium oxide and citric acid; Sodium picosulfate/magnesium citrate laxative; Sulfate, magnesium; | - |
- |
- |
006 17件: 6 , 11, 13, 46, 51, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
171 | Magnesium oxide | Magnesium oxide 2件: Magnesium oxide; Sodium picosulfate, magnesium oxide and citric acid; | 1件: D01167 D01167 💬 |
- |
- |
006 3件: 6 , 166, 291 💬 |
172 | Maltodextrin | Maltodextrin 3件: Maltodextrin; Maltodextrin fiber supplement; Resistant maltodextrin; | 1件: D02329 D02329 💬 |
- |
- |
006 4件: 6 , 13, 96, 97 💬 |
173 | Mannitol | Dp mannitol 7件: Dp mannitol; Idpm: inhaled dry powder mannitol; Inhaled dry powder mannitol; Inhaled mannitol; Mannitol; Mannitol + pulmozyme; Mannitol inhalation powder; | 1件: D00062 D00062 💬 |
- |
- |
006 4件: 6 , 60, 96, 299 💬 |
174 | Masitinib | Masitinib 12件: Masitinib; Masitinib (3.0); Masitinib (4.5); Masitinib (6.0); Masitinib (ab1010); Masitinib 100 mg tablets; Masitinib 100mg; Masitinib 200 mg tablets; Masitinib 200mg; Masitinib 3 mg; Masitinib 6.0 mg; Masitinib mesylate; | 1件: D10229 D10229 💬 |
1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
175 | Mavoglurant | Mavoglurant 1件: Mavoglurant; | - |
- |
- |
006 2件: 6 , 206 💬 |
176 | Medical Cannabis | - | - |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
177 | Medium-chain triglycerides | - | - |
- |
- |
006 3件: 6 , 96, 318 💬 |
178 | Melatonin | 3 mg melatonin 11件: 3 mg melatonin; 5 mg melatonin; Circadin ( inn= melatonin); Diazepam, melatonin; Dtr melatonin (nih cc pds); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin; Melatonin cr; Melatonin pr; Melatonin(circadin®); Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.; | 1件: D08170 D08170 💬 |
2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
179 | Melevodopa | Melevodopa 2件: Melevodopa; Melevodopa and decarboxylase inhibitor; | 1件: D07304 D07304 💬 |
- |
- |
006 1件: 6 💬 |
180 | Melperone | Melperone 2件: Melperone; Melperone hcl; | 1件: D07309 D07309 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
181 | Memantine | Memantine 5件: Memantine; Memantine (drug); Memantine (ebixa); Memantine hydrochloride; Memantine hydrochloride oral solution; | 2件: D04905 D04905
D08174 D08174 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 7件: 2 , 6 , 8 , 13, 49, 127, 205 💬 |
182 | Mesdopetam | Mesdopetam 2件: Mesdopetam; Mesdopetam (irl790); | - |
- |
- |
006 1件: 6 💬 |
183 | Metformin | 750 mg metformin and 7.5 g l-citrulline daily p.o. 21件: 750 mg metformin and 7.5 g l-citrulline daily p.o.; Glucophage (metformin); L-citrulline and metformin & l-citrulline; Metformin; Metformin (generic); Metformin 500mg; Metformin and metformin & l-citrulline; Metformin hcl; Metformin hydrochloride; Metformin treatment; Metformin/cp-690,550; Metformina; Metformina - 500 30 compresse 500 mg; Metformine; Metformine arrow 500mg; Metformine hcl 500 pch; Metformine sandoz 850 mg filmomhulde tabletten; Other: metformin; Pioglitazone or metformin; Sitagliptin and metformin; [metformina]; | 2件: D00944 D00944
D04966 D04966 💬 |
2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
184 | Methylphenidate | D-methylphenidate 11件: D-methylphenidate; Methylphenidate; Methylphenidate (mpd); Methylphenidate (overencapsulated); Methylphenidate 10mg tablets; Methylphenidate hydrochloride; Methylphenidate modified release; Methylphenidate modified release 20 mg; Methylphenidate modified release 30 mg; Methylphenidate modified release 40 mg; Methylphenidate, fluoxetin, risperidone; | 2件: D01296 D01296
D04999 D04999 💬 |
2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 7件: 6 , 13, 34, 84, 113, 179, 206 💬 |
185 | Methylprednisolone | Administration of rituximab and methylprednisolone 35件: Administration of rituximab and methylprednisolone; Corticosteroid treatment (methylprednisolone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Infliximab, methylprednisolone, methotrexate; Interferon-beta-1a (avonex) plus methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Intravenous methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methotrexate + methylprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone (mp); Methylprednisolone (mp) or prednisone (pred); Methylprednisolone (or other glucocorticoid); Methylprednisolone (solu-medrol); Methylprednisolone 1250 mg/24h x3 days; Methylprednisolone acetate; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone mylan générique; Methylprednisolone or budesonide; Methylprednisolone or prednisolone; Methylprednisolone po; Methylprednisolone pulse; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Oral methylprednisolone 625 mg/24h x3 days; Prednisone (and methylprednisolone); Prednisone, methylprednisolone,cyclophosphamides; | 6件: D00407 D00407
D00751 D00751
D00979 D00979
D05000 D05000
D05001 D05001
D05002 D05002 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
186 | Midazolam | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 7件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Midazolam; Midazolam 2 mg; Midazolam 3 mg; Midazolam injection; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; S-ketamine & midazolam; | 3件: D00550 D00550
D00696 D00696
D05028 D05028 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
187 | Midodrine | Midodrine 2件: Midodrine; Midodrine hydrochloride; | 2件: D01307 D01307
D08220 D08220 💬 |
3件: ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 3件: 6 , 17, 58 💬 |
188 | Minocycline | Combination of minocycline and mtx or mtx alone 8件: Combination of minocycline and mtx or mtx alone; Glatiramer acetate with minocycline; Lovastatin, then minocycline/lovastatin; Minocycline; Minocycline 100 mg film-coated tablets; Minocycline 100mg; Minocycline hydrochloride; Minocycline, then minocycline/lovastatin; | 2件: D00850 D00850
D05045 D05045 💬 |
- |
- |
002 14件: 2 , 6 , 8 , 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
189 | Minodronic acid | Minodronic acid 1件: Minodronic acid; | - |
- |
- |
006 4件: 6 , 46, 93, 95 💬 |
190 | Mirabegron | Mirabegron 1件: Mirabegron; | 1件: D09535 D09535 💬 |
1件: ADRB3 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway |
006 3件: 6 , 13, 226 💬 |
191 | Mitoquinone | Mitoquinone 1件: Mitoquinone; | - |
- |
- |
006 3件: 6 , 13, 97 💬 |
192 | Moclobemide | Moclobemide 1件: Moclobemide; | 1件: D02561 D02561 💬 |
1件: MAOA 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
193 | Modafinil | Armodafinil 5件: Armodafinil; Modafinil; Modafinil 50mg; Over-encapsulated modafinil; Provigil (modafinil); | 1件: D01832 D01832 💬 |
- |
- |
006 4件: 6 , 13, 49, 93 💬 |
194 | Moxifloxacin | Avelox- moxifloxacin 6件: Avelox- moxifloxacin; Moxifloxacin; Moxifloxacin 400 mg; Moxifloxacin hydrochloride; Moxifloxacin infusion; Moxifloxacina cloridrato; | 2件: D00874 D00874
D08237 D08237 💬 |
- |
- |
002 8件: 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
195 | Muscimol | Muscimol 1件: Muscimol; | - |
- |
- |
006 1件: 6 💬 |
196 | Nabilone | Cesamet™ (nabilone) 3件: Cesamet™ (nabilone); Nabilone; Nabilone 0.25 mg; | 1件: D05099 D05099 💬 |
2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 2件: 6 , 13 💬 |
197 | Nalmefene | Nalmefene 1件: Nalmefene; | 1件: D05111 D05111 💬 |
3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
198 | Naloxone | Naloxone 12件: Naloxone; Naloxone hydrochloride; Naloxone hydrochloride dihydrate; Oxycodone naloxone prolonged release tablets; Oxycodone/naloxone prolonged release t; Oxycodone/naloxone prolonged release tablets; Oxycodone/naloxone prolonged release tablets 10 mg /5 mg; Oxycodone/naloxone prolonged release tablets 10/5 mg; Oxycodone/naloxone prolonged release tablets 20 mg /10 mg; Oxycodone/naloxone prolonged release tablets 20/10 mg; Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg; Oxycodone/naloxone prolonged release tablets 5/2.5 mg; | 2件: D01340 D01340
D08249 D08249 💬 |
3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 2件: 6 , 226 💬 |
199 | Naltrexone | 4.5 mg naltrexone 6件: 4.5 mg naltrexone; Low dose naltrexone; Low-dose naltrexone; Naltrexone; Naltrexone hydrochloride; Naltrexone-hcl; | 2件: D02095 D02095
D05113 D05113 💬 |
3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 13件: 6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬 |
200 | Nebicapone | Nebicapone 1件: Nebicapone; | - |
- |
- |
006 1件: 6 💬 |
201 | Nelotanserin | Nelotanserin 1件: Nelotanserin; | 1件: D09645 D09645 💬 |
1件: HTR2A 💬 |
Calcium signaling pathway 5件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse |
006 1件: 6 💬 |
202 | Neridronic Acid | Neridronic acid 1件: Neridronic acid; | - |
- |
- |
006 1件: 6 💬 |
203 | Niacin | Dose-establishing study 1 niacin 250mg 6件: Dose-establishing study 1 niacin 250mg; Dose-establishing study 1 niacin 500mg; Dose-establishing study 2 niacin 500mg; Niacin; Niacin first; Niacinamide; | 1件: D00049 D00049 💬 |
- |
- |
006 4件: 6 , 78, 79, 265 💬 |
204 | Nicotinamide | Eh301 (nicotinamide riboside/pterostilbene) 3件: Eh301 (nicotinamide riboside/pterostilbene); Nicotinamide; Nicotinamide riboside; | 1件: D00036 D00036 💬 |
- |
- |
002 9件: 2 , 5 , 6 , 13, 18, 49, 67, 162, 191 💬 |
205 | Nicotinamide riboside | Eh301 (nicotinamide riboside/pterostilbene) 2件: Eh301 (nicotinamide riboside/pterostilbene); Nicotinamide riboside; | - |
- |
- |
002 4件: 2 , 6 , 18, 191 💬 |
206 | Nicotine | Nicotine 9件: Nicotine; Nicotine gum; Nicotine nasal spray 10 mg/ml (0.5 mg/spray); Nicotine patch; Nicotine transdermal patch; Nicotinell; Nicotinell 17,5 mg/24-stunden-pflaster; Nicotinell 35 mg/24-stunden-pflaster; Transdermal nicotine; | 3件: D03365 D03365
D05156 D05156
D05157 D05157 💬 |
16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 2件: 6 , 84 💬 |
207 | Nilotinib | Cohort 1:nilotinib oral capsules (150mg or 300mg) 9件: Cohort 1:nilotinib oral capsules (150mg or 300mg); Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1); Nilotinib; Nilotinib (tasigna); Nilotinib 150 mg; Nilotinib 150mg oral capsule [tasigna]; Nilotinib 300mg oral capsule [tasigna]; Nilotinib 50 mg; Nilotinib hydrochloride monohydrate; | 1件: D08953 D08953 💬 |
4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 5件: 6 , 8 , 34, 51, 86 💬 |
208 | Nitrogen | Device: perform three multiple breath nitrogen washout tests (n2-mbw-test) 3件: Device: perform three multiple breath nitrogen washout tests (n2-mbw-test); Nitrogen; Procedure: functional hepatic nitrogen clearance; | 1件: D00083 D00083 💬 |
- |
- |
005 6件: 5 , 6 , 17, 171, 211, 299 💬 |
209 | Nortriptyline | Nortriptyline 2件: Nortriptyline; Nortriptyline hydrochloride; | 2件: D00816 D00816
D08288 D08288 💬 |
2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 226 💬 |
210 | Omeprazole | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 19件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Clartihromycin, amoxicillin, and omeprazole; Diclofenac + omeprazole; Dimebon + omeprazole; Esomeprazole; Esomeprazole 20 mg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Nexium (esomeprazole magnesium); Omeprazole; Omeprazole (uk licensed generic product); Omeprazole 20 mg; Omeprazole 20mg; Omeprazole 20mg bid; Omeprazole 40 mg; Omeprazole 40mg capsule; Omeprazole magnesium; Omeprazole rectally 1mg/kg; Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); Rifaximin+omeprazole+miralax; | 4件: D00455 D00455
D01207 D01207
D05259 D05259
D05261 D05261 💬 |
2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
211 | Ondansetron | Ondansetron 3件: Ondansetron; Ondansetron 8 mg film-coated tablets; Ondansetron hydrochloride dihydrate; | 2件: D00456 D00456
D00678 D00678 💬 |
5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Taste transduction |
006 3件: 6 , 97, 231 💬 |
212 | Opicapone | Opicapone 2件: Opicapone; Opicapone (opc); | 1件: D10825 D10825 💬 |
1件: COMT 💬 |
Dopaminergic synapse 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 1件: 6 💬 |
213 | Oxybuprocaine | Oxybuprocaine 1件: Oxybuprocaine; | 2件: D01768 D01768
D08319 D08319 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 1件: 6 💬 |
214 | Oxybutynin | Oxybutynin 3件: Oxybutynin; Oxybutynin and darifenacin; Oxybutynin hydrochloride; | 2件: D00465 D00465
D00722 D00722 💬 |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 2件: 6 , 13 💬 |
215 | Oxycodone | Extended-release oxycodone 17件: Extended-release oxycodone; Oxycodone; Oxycodone by patient-controlled analgesia (pca); Oxycodone depot ”sandoz”, depot tablets; Oxycodone hydrochloride; Oxycodone naloxone prolonged release tablets; Oxycodone orion; Oxycodone/acetaminophen; Oxycodone/naloxone prolonged release t; Oxycodone/naloxone prolonged release tablets; Oxycodone/naloxone prolonged release tablets 10 mg /5 mg; Oxycodone/naloxone prolonged release tablets 10/5 mg; Oxycodone/naloxone prolonged release tablets 20 mg /10 mg; Oxycodone/naloxone prolonged release tablets 20/10 mg; Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg; Oxycodone/naloxone prolonged release tablets 5/2.5 mg; Pr oxycodone; | 3件: D03783 D03783
D05312 D05312
D05462 D05462 💬 |
3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 7件: 6 , 13, 46, 70, 226, 231, 298 💬 |
216 | Oxygen | Behavioral: respiratory and exercise therapy with supplemental oxygen 39件: Behavioral: respiratory and exercise therapy with supplemental oxygen; Combination product: hyperbaric oxygen therapy-; Continuous oxygen; Device: auto-titrating oxygen system; Device: capacity of muscular oxygen extraction; Device: high flow nasal oxygen cannula; Device: hyperbaric oxygen; Device: intermittent exposure to oxygen via oro-nasal mask; Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation; Device: oxygen; Device: oxygen saturation; Device: standard oxygen therapy/ra; Diagnostic test: maximum oxygen uptake; Helium / oxygen mixed gas inhalation therapy; Medical air vs oxygen; Medical grade oxygen; Nitric oxide plus oxygen; Other: 60% oxygen; Other: air - oxygen; Other: hyperbaric oxygen; Other: hyperbaric oxygen therapy; Other: muscle oxygenation; Other: optional blood-oxygen-level dependent functionalmri; Other: oxygen; Other: oxygen (2liter/min); Other: oxygen (4liter/min); Other: oxygen - air; Other: oxygen supplementation; Oxygen; Oxygen 40 %; Oxygen supplementation; Oxygen, liquid; Perfluorinated gas/oxygen mixture; Procedure: hyperbaric oxygen; Procedure: hyperbaric oxygen therapy; Procedure: long term oxygen therapy; Procedure: oxygen flow at the optic nerve head measurement; Procedure: supplemental oxygen via a mask; Standard analgesia use [oxygen]; | 1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
217 | Oxytocin | Intranasal oxytocin 8件: Intranasal oxytocin; Intranasal oxytocin (in-oxt); Oxytocin; Oxytocin (oxt) continuous; Oxytocin 24iu; Oxytocin 48iu; Oxytocin synthetic; Synthetic oxytocin; | 1件: D00089 D00089 💬 |
1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
006 5件: 6 , 127, 193, 206, 226 💬 |
218 | Pardoprunox | Pardoprunox 2件: Pardoprunox; Pardoprunox hydrochloride; | 1件: D09397 D09397 💬 |
3件: DRD2, DRD3, HTR1A 💬 |
Alcoholism 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 1件: 6 💬 |
219 | Paroxetine | Paroxetine 4件: Paroxetine; Paroxetine & prednisolone; Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp; Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp; | 4件: D02260 D02260
D02362 D02362
D05374 D05374
D05375 D05375 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 3件: 6 , 13, 46 💬 |
220 | Perampanel | 2 mg perampanel 3件: 2 mg perampanel; 4 mg perampanel; Perampanel; | 1件: D08964 D08964 💬 |
4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 3件: 2 , 6 , 144 💬 |
221 | Pergolide | Pergolide 1件: Pergolide; | 2件: D00502 D00502
D08339 D08339 💬 |
2件: DRD1, DRD2 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
222 | Phenelzine | - | 2件: D00505 D00505
D08349 D08349 💬 |
2件: MAOA, MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
223 | Phenylbutyric acid | - | 1件: D05868 D05868 💬 |
- |
- |
002 12件: 2 , 3 , 6 , 8 , 15, 93, 94, 231, 244, 251, 297, 299 💬 |
224 | Piclozotan | Piclozotan 1件: Piclozotan; | - |
- |
- |
006 1件: 6 💬 |
225 | Pilocarpine | Diagnostic test: iontophoresis sessions in forearm of subjects with pilocarpine 5件: Diagnostic test: iontophoresis sessions in forearm of subjects with pilocarpine; Pilocarpine; Pilocarpine hydrochloride; Pilocarpine nitrate 5%; Procedure: pilocarpine; | 3件: D00525 D00525
D02200 D02200
D05478 D05478 💬 |
2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 3件: 6 , 53, 299 💬 |
226 | Pimavanserin | Active drug: pimavanserin 17mg (2 strength tablets) 5件: Active drug: pimavanserin 17mg (2 strength tablets); Pimavanserin; Pimavanserin (acp-103); Pimavanserin tartrate; Pimavanserin tartrate (acp-103); | - |
- |
- |
006 1件: 6 💬 |
227 | Pioglitazone | Actos (pioglitazone) 6件: Actos (pioglitazone); Pioglitazone; Pioglitazone 15 mg; Pioglitazone and tretinoin; Pioglitazone or metformin; Tretinoin and pioglitazone hcl; | 2件: D00945 D00945
D08378 D08378 💬 |
1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
228 | Piribedil | Piribedil 2件: Piribedil; Piribedil (clarium); | 1件: D07305 D07305 💬 |
2件: DRD2, DRD3 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
229 | Pitolisant | Bf2.649 (pitolisant) 3件: Bf2.649 (pitolisant); Pitolisant; Pitolisant oral tablets; | 1件: D10749 D10749 💬 |
1件: HRH3 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 2件: 6 , 193 💬 |
230 | Pittsburgh Compound B | Other: pittsburgh compound b [11c]-pib 3件: Other: pittsburgh compound b [11c]-pib; Pittsburgh compound b; Pittsburgh compound b (c-11 pib); | - |
- |
- |
006 2件: 6 , 127 💬 |
231 | Polyethylene glycol | 2l polyethylene glycol/ascorbic acid 6件: 2l polyethylene glycol/ascorbic acid; C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker; Polyethylene glycol; Polyethylene glycol 3350; Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker; Treatment with polyethylene glycol (macrogol 4000); | 1件: D03370 D03370 💬 |
- |
- |
006 11件: 6 , 13, 46, 65, 78, 96, 97, 235, 240, 276, 299 💬 |
232 | Posiphen | Posiphen 1件: Posiphen; | - |
- |
- |
006 1件: 6 💬 |
233 | Potassium carbonate | - | 1件: D02038 D02038 💬 |
- |
- |
006 3件: 6 , 96, 291 💬 |
234 | Pramipexole | Cimetidine plus dexpramipexole 28件: Cimetidine plus dexpramipexole; Dexpramipexole; Dexpramipexole (dose 1); Dexpramipexole (dose 2); Dexpramipexole dichydrochloride; Dexpramipexole dihydrochloride; Dopamine agonists (pramipexole, ropirinole); Mirapex (pramipexole); P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Pramipexole; Pramipexole 0.125 mg tablets; Pramipexole 0.5 mg tablets; Pramipexole dihydrochloride; Pramipexole dihydrochloride extended-release tablets; Pramipexole dihydrochloride monohydrate; Pramipexole dihydrochloride monohydrate extended release; Pramipexole er; Pramipexole extended release; Pramipexole extended release tablet; Pramipexole hydrochloride sustained-release tablet (siforl®) specification: 0.26mg/ tablet (in pramipexole); Pramipexole immediate release; Pramipexole immediate release tablet; Pramipexole ir; Pramipexole or ropinirole; Pramipexole sr; Praxol hydrochloride sustained release tablet specification: 0.375mg/ tablet (in pramipexole hydrochloride); R(+) pramipexole dihydrochloride monohydrate; | 2件: D00559 D00559
D05575 D05575 💬 |
3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 2件: 2 , 6 💬 |
235 | Prednisone | 0 mg prednisone 73件: 0 mg prednisone; 5 mg prednisone; 5-aminosalicylic acid(5-asa) and/or prednisone; Adalimumab, plus prednisone; Azathioprine/prednisone; Chinese herb prescription granule plus prednisone; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide-prednisone-azathioprine; Enalapril valsartan methylprednisone; Glucocorticoid (prednisone or prednisolone); Granulocyte-colony stimulating factor (g-csf) and prednisone; Hormone (prednisone); Hydroxychloroquine + prednisone; Ir prednisone; Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Methylprednisone; Mr prednisone; Mycophenolate mofetil plus lower dose of prednisone; Oral prednisone; Oral prednisone 5mg; Other: prednisone; Over encapsulated prednisone; Prednisolone/prednisone; Prednisone; Prednisone (and methylprednisolone); Prednisone + inhibace/cozaar; Prednisone - azathioprine; Prednisone 0,5 mg/kg orally on alternate days; Prednisone 1 mg; Prednisone 15 mg; Prednisone 2 mg; Prednisone 3 mg; Prednisone 4 mg; Prednisone 5 mg; Prednisone 5 mg tablets; Prednisone 7.5 mg; Prednisone acetate; Prednisone acetate tablets; Prednisone alone; Prednisone and belimumab; Prednisone and cyclophosphamide; Prednisone and mycophenolate mofetil; Prednisone and ustekinumab treatment; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone capsules; Prednisone discontinuation; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Prednisone, ciclosporin and mycophenolate mofetil; Prednisone, cyclophosphamide; Prednisone, fk506, mmf; Prednisone, low dose rituximab; Prednisone, methylprednisolone,cyclophosphamides; Prednisone/prednisolone; Procedure: thymectomy plus prednisone; Rayos (delayed-release prednisone); Sotatercept with prednisone boost; Tacrolimus combined with prednisone; Thalidomide, cyclophosphamide and prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Ursodeoxycholic acid+low dose glucocorticoid(prednisone); | 1件: D00473 D00473 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
236 | Preladenant | Preladenant 4件: Preladenant; Preladenant 10 mg tablet; Preladenant 2 mg tablet; Preladenant 5 mg tablet; | 1件: D09717 D09717 💬 |
1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
237 | Pridopidine | Pridopidine 3件: Pridopidine; Pridopidine (90 mg); Pridopidine hydrochloride; | 1件: D09953 D09953 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 3件: 2 , 6 , 8 💬 |
238 | Propanoic acid | (+)-(s)-2-(6-methoxynaphthalen-2-yl) propanoic acid 6件: (+)-(s)-2-(6-methoxynaphthalen-2-yl) propanoic acid; (minus)-l-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate; Ph. eur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; Pheur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; Pheur.: (2s)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid; Propanoic acid; | 1件: D02310 D02310 💬 |
- |
- |
006 2件: 6 , 271 💬 |
239 | Propofol | Device: propofol dosage 5件: Device: propofol dosage; Intubated with propofol (ip); Procedure: sedation with iv propofol; Propofol; Propofol-lipuro; | 1件: D00549 D00549 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 9件: 6 , 21, 22, 34, 46, 75, 84, 98, 296 💬 |
240 | Propranolol | Atenolol or propranolol 5件: Atenolol or propranolol; Losartan and atenolol or propranolol; Propranolol; Propranolol hcl cf 40 mg tablet; Propranolol treatment; | 2件: D00483 D00483
D08443 D08443 💬 |
3件: ADRB1, ADRB2, ADRB3 💬 |
Adrenergic signaling in cardiomyocytes 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 6件: 6 , 158, 167, 227, 278, 296 💬 |
241 | Pyridostigmine | Pyridostigmine 2件: Pyridostigmine; Pyridostigmine bromide; | 1件: D00487 D00487 💬 |
1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
003 4件: 3 , 6 , 11, 256 💬 |
242 | Pyridoxine | Pyridoxine 4件: Pyridoxine; Pyridoxine 10mg; Pyridoxine 10mg bp; Pyridoxine plus prednisolone; | 2件: D02179 D02179
D08454 D08454 💬 |
- |
- |
006 3件: 6 , 93, 145 💬 |
243 | Pyrimethamine | Fansidar (pyrimethamine and sulfadoxine) 2件: Fansidar (pyrimethamine and sulfadoxine); Pyrimethamine; | 1件: D00488 D00488 💬 |
- |
- |
002 10件: 2 , 4 , 6 , 19, 46, 51, 65, 96, 97, 265 💬 |
244 | Quetiapine | Extended-release quetiapine fumarate 2件: Extended-release quetiapine fumarate; Quetiapine; | 2件: D00458 D00458
D08456 D08456 💬 |
2件: DRD2, HTR2A 💬 |
Alcoholism 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
006 2件: 6 , 13 💬 |
245 | Raclopride | 11c-raclopride 2件: 11c-raclopride; Raclopride; | - |
- |
- |
005 4件: 5 , 6 , 7 , 17 💬 |
246 | Ramelteon | Ramelteon 1件: Ramelteon; | 1件: D02689 D02689 💬 |
2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 3件: 6 , 8 , 46 💬 |
247 | Rasagiline | 1.0 mg rasagiline mesylate 16件: 1.0 mg rasagiline mesylate; Group r rasagiline; Group r+ad rasagiline + antidepressant; P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Rasagiline; Rasagiline 1 mg capsule; Rasagiline 1mg tablet; Rasagiline 2 mg tablet; Rasagiline mesilate; Rasagiline mesylate; Rasagiline mesylate 1.0 mg; Rasagiline mesylate plus mirapex; Rasagiline mesylate with levodopa; Rasagiline mesylate with requip; Rasagiline tablets; | 3件: D02562 D02562
D08469 D08469
D10829 D10829 💬 |
1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 6件: 2 , 5 , 6 , 13, 17, 66 💬 |
248 | Remifentanil | Remifentanil 1件: Remifentanil; | 2件: D01177 D01177
D08473 D08473 💬 |
1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
006 2件: 6 , 70 💬 |
249 | Repaglinide | Repaglinide 2件: Repaglinide; Repaglinide and insulin; | 1件: D00594 D00594 💬 |
2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
006 3件: 6 , 21, 299 💬 |
250 | Reynoutria multiflora root | - | - |
- |
- |
006 1件: 6 💬 |
251 | Rifampicin | Rifampicin 1件: Rifampicin; | 1件: D00211 D00211 💬 |
- |
- |
006 8件: 6 , 13, 17, 46, 84, 86, 93, 299 💬 |
252 | Rifaximin | Rifaximin 10件: Rifaximin; Rifaximin 550 mg; Rifaximin delayed release (dr); Rifaximin delayed release 400 mg film coated tablet; Rifaximin delayed release tablets; Rifaximin eir; Rifaximin oral tablet; Rifaximin+omeprazole+miralax; Rifaximin-eir; Rifaximina; | 1件: D02554 D02554 💬 |
- |
- |
006 7件: 6 , 65, 94, 96, 97, 99, 296 💬 |
253 | Rivastigmine | Exelon patch (rivastigmine transdermal system) 9件: Exelon patch (rivastigmine transdermal system); Rivastigmine; Rivastigmine capsule; Rivastigmine cf; Rivastigmine luye transdermal patch- 9.5mg/24h; Rivastigmine patch 9.5 cm2; Rivastigmine transdermal patch; Rivastigmine transdermal system; Rivastigmine transdermal system 13.3 mg/24 h; | 2件: D02558 D02558
D03822 D03822 💬 |
1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 3件: 5 , 6 , 13 💬 |
254 | Ropinirole | Hp-3000 (ropinirole hydrochloride patch) 27件: Hp-3000 (ropinirole hydrochloride patch); Hp-3000(ropinirole hydrochloride patch); Pramipexole or ropinirole; Ropinirole; Ropinirole (as hydrochloride); Ropinirole controlled-release (requip cr) for rls; Ropinirole cr 2mg tablet; Ropinirole cr 8mg tablet; Ropinirole hydrochloride; Ropinirole hydrochloride extended-release tablet; Ropinirole hydrochloride extended-release tablet placebo; Ropinirole hydrochloride prolonged release; Ropinirole immediate release; Ropinirole implant; Ropinirole ir; Ropinirole ir tablets; Ropinirole monotherapy; Ropinirole oral product; Ropinirole pr; Ropinirole pr, 2mg; Ropinirole pr/xr; Ropinirole pr/xr tablets; Ropinirole prolonged release; Ropinirole prolonged release/extended release(pr/xr); Ropinirole xl; Ropinirole xl (formerly cr); Ropinirole/l-dopa; | 2件: D00784 D00784
D08489 D08489 💬 |
3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 4件: 2 , 6 , 74, 309 💬 |
255 | Rosuvastatin | Calcium rosuvastatin 8件: Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Rosuvastatin; Rosuvastatin 10 mg; Rosuvastatin 20mg; Rosuvastatin calcium; Rosuvastatin calcium 40mg; Rosuvastatine eg; | 2件: D01915 D01915
D08492 D08492 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
256 | Rotigotine | Ly03003 ( rotigotine, extended-release microspheres) 17件: Ly03003 ( rotigotine, extended-release microspheres); Ly03003 (rotigotine extended release microspheres for intramuscular [im] injection); Ly03003( the name of rotigotine); Ly03003(rotigotine,extended-release microspheres); Other: rotigotine; Rotigotine; Rotigotine (reference product pr 2.1.1); Rotigotine (test product pr 2.3.1); Rotigotine hydrochloride; Rotigotine nasal spray; Rotigotine transdermal patch; Rotigotine transdermal patch 2mg/24h(10cm2); Rotigotine transdermal patch 4mg/24h (20cm2); Rotigotine transdermal patch 6mg/24h (30cm2); Rotigotine transdermal patch 8mg/24h (40cm2); Rotigotine tts (test); Rotigotine, extended-release microspheres; | 1件: D05768 D05768 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
257 | Safinamide | Me2125 (safinamide mesilate) 12件: Me2125 (safinamide mesilate); Safinamide; Safinamide (as add-on therapy); Safinamide + levodopa; Safinamide metansolfonato; Safinamide metansolfonato (12 weeks); Safinamide methanesulfonate; Safinamide methanesulfonate 100mg; Safinamide methanesulfonate 150mg; Safinamide methansulfonate; Safinamide, mao-b inhibitor; Xadago (safinamide); | 1件: D10158 D10158 💬 |
1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
258 | Sage | Device: massage with a spiky ball 8件: Device: massage with a spiky ball; Sage; Sage leaf; Sage-217; Sage-718; Thn102 dosage a; Thn102 dosage b; Thn102 dosage c; | - |
- |
- |
006 1件: 6 💬 |
259 | Saracatinib | Saracatinib 2件: Saracatinib; Saracatinib difumarate; | 1件: D09664 D09664 💬 |
2件: ABL1, SRC 💬 |
Adherens junction 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
006 3件: 6 , 89, 272 💬 |
260 | Sarcosine | Sarcosine 2件: Sarcosine; Sarcosine capsule; | - |
- |
- |
006 1件: 6 💬 |
261 | Sargramostim | Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim) 4件: Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim); Gm-csf [leukine (sargramostim)]; Sargramostim; Sargramostim (leukine); | 1件: D05803 D05803 💬 |
1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
006 7件: 6 , 28, 60, 62, 96, 229, 285 💬 |
262 | Sarizotan | Sarizotan 4件: Sarizotan; Sarizotan hc1; Sarizotan hcl; Sarizotan hydrochloride; | - |
- |
- |
006 2件: 6 , 156 💬 |
263 | Selegiline | Orally disintegrating selegiline (zelapar) 3件: Orally disintegrating selegiline (zelapar); Selegiline; Selegiline hcl 5 pch; | 2件: D00785 D00785
D03731 D03731 💬 |
1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
264 | Semaglutide | Semaglutide 1件: Semaglutide; | 1件: D10025 D10025 💬 |
1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 1件: 6 💬 |
265 | SEP-363856 | Sep-363856 1件: Sep-363856; | - |
- |
- |
006 1件: 6 💬 |
266 | Serine | D-serine 4件: D-serine; D-serine (~2g/day); L-serine; Serine; | 1件: D00016 D00016 💬 |
- |
- |
002 3件: 2 , 6 , 86 💬 |
267 | Sertraline | Sertraline 1件: Sertraline; | 2件: D00825 D00825
D02360 D02360 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 206 💬 |
268 | Sevoflurane | Intubated with sevoflurane (is) 3件: Intubated with sevoflurane (is); Sevoflurane; Sevoflurane anesthetics; | 1件: D00547 D00547 💬 |
- |
- |
006 6件: 6 , 21, 22, 34, 98, 296 💬 |
269 | Sildenafil | 20 mg sildenafil citrate by mouth 32件: 20 mg sildenafil citrate by mouth; 5% sildenafil cream; Access program - sildenafil citrate, viagra, revatio; Bosentan and sildenafil; Duo-therapy with sildenafil + bosentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); G04be03- sildenafil - sildenafil (citrato); Mono-therapy with sildenafil; Oral sildenafil; Other: standard of care sildenafil; Sildenafil; Sildenafil (50 mg); Sildenafil (acute-1 hour); Sildenafil (as citrate); Sildenafil (revatio); Sildenafil (revatio) 20 mg tid; Sildenafil (subchronic-4 weeks); Sildenafil 20 mg tablets; Sildenafil 20mg; Sildenafil 20mg and bosentan 62.5mg; Sildenafil 40mg oral capsule; Sildenafil and losartan; Sildenafil by injection; Sildenafil citrate; Sildenafil citrate (uk-92,480); Sildenafil filmtabletten; Sildenafil singly or in association with bosentan; Sildenafil therapy; Sildenafilo; Sitaxsentan and sildenafil; Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth; Tadalafil and sildenafil; | 2件: D02229 D02229
D08514 D08514 💬 |
1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
270 | Silicon | Device: nj-tube: silicon ed tube 2件: Device: nj-tube: silicon ed tube; Silicon; | - |
- |
- |
006 1件: 6 💬 |
271 | Silodosin | Silodosin 1件: Silodosin; | 1件: D01965 D01965 💬 |
1件: ADRA1A 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 2件: 6 , 13 💬 |
272 | Simvastatin | Encapsulated simvastatin tablets 21件: Encapsulated simvastatin tablets; Ezetimibe+simvastatin drug combination; Other: simvastatin; Simvastatin; Simvastatin 20 mg; Simvastatin 20mg/5ml oral suspension; Simvastatin 40 mg; Simvastatin 40 mg film-coated tablets; Simvastatin 40 mg tablets; Simvastatin 40mg; Simvastatin alternova; Simvastatin in relapsing remitting multiple sclerosis; Simvastatin susp.; Simvastatin treatment for 28 days; Simvastatin-ratiopharm; Simvastatin-ratiopharm®; Simvastatina; Simvastatina sandoz 40 mg comprimidos recubiertos con película efg; Simvastatine; Simvastatine sandoz 40 mg filmomhulde tabletten; Simvastatine sandoz 40mg deelbare filmomhulde tabletten; | 1件: D00434 D00434 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 21件: 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
273 | Sirolimus | Rapamycin, sirolimus 22件: Rapamycin, sirolimus; Sirolimus; Sirolimus (formerly known as rapamycin); Sirolimus (study drug)+ace inhibitor + statin; Sirolimus 0,1% crème; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 1mg/ml; Sirolimus 2 mg; Sirolimus 2%; Sirolimus and hydroxychloroquine 200 mg; Sirolimus and hydroxychloroquine 400 mg; Sirolimus ointment; Sirolimus oral liquid product 1mg/ml; Sirolimus oral product; Sirolimus, 2%; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Tavt-18 (sirolimus); Temsirolimus; Temsirolimus tablets; Topical 0.1% sirolimus; | 1件: D00753 D00753 💬 |
1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
274 | Sitagliptin | Sitagliptin 2件: Sitagliptin; Sitagliptin and metformin; | 1件: D08516 D08516 💬 |
1件: DPP4 💬 |
Protein digestion and absorption 1件: Protein digestion and absorption |
006 4件: 6 , 75, 233, 299 💬 |
275 | Smilagenin | Smilagenin 1件: Smilagenin; | - |
- |
- |
006 1件: 6 💬 |
276 | Sodium chloride | 0.9% sodium chloride 24件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); 0.9% sodium chloride injection; 0.9% w/v isotonic sodium chloride solution; 0.9% w/v sodium chloride solution; Isotonic sodium chloride solution; Other: 0.9% sodium chloride; Other: 0.9ml sodium chloride; Other: sodium chloride; Physiological serum (sodium chloride); Procedure: 9% sodium chloride (nacl) iv; Sodium chloride; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 0.9%; Sodium chloride 6%; Sodium chloride 7%; Sodium chloride ph. eur.; Sodium chloride solution; Sodium chloride solution 0.9%; Sodium chloride solvent; Sodium pyruvate in 0.9% sodium chloride solution; Solucion de cloruro de sodio sodium chloride solution; Solvente cloruro de sodio sodium chloride solvent; | 1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
277 | Sodium oxybate | Sodium oxybate 1件: Sodium oxybate; | 1件: D05866 D05866 💬 |
- |
- |
006 2件: 6 , 149 💬 |
278 | Solifenacin | Solifenacin 3件: Solifenacin; Solifenacin succinate; Solifenacin succinate (vesicare); | 2件: D01269 D01269
D08522 D08522 💬 |
1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 2件: 6 , 13 💬 |
279 | Sorbitol | D-sorbitol 2件: D-sorbitol; Sorbitol; | 1件: D00096 D00096 💬 |
- |
- |
006 4件: 6 , 10, 28, 299 💬 |
280 | Sulfanilamide | - | 1件: D08543 D08543 💬 |
- |
- |
006 5件: 6 , 30, 60, 118, 298 💬 |
281 | Sulfate ion | - | - |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
282 | Sulpiride | - | 2件: D01226 D01226
D08549 D08549 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 5件: 2 , 6 , 17, 46, 70 💬 |
283 | Sumanirole | Sumanirole 1件: Sumanirole; | - |
- |
- |
006 1件: 6 💬 |
284 | Suvorexant | Suvorexant 1件: Suvorexant; | 1件: D10082 D10082 💬 |
2件: HCRTR1, HCRTR2 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
005 3件: 5 , 6 , 13 💬 |
285 | Tacrolimus | Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf 17件: Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Interferon beta-1b and tacrolimus; Lcp-tacro (tacrolimus); Rectal tacrolimus; Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil); Tacrolimus; Tacrolimus (advagraf); Tacrolimus (prograf®); Tacrolimus (tacro); Tacrolimus and mmf; Tacrolimus capsule; Tacrolimus capsule (low-dose); Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus prolonged-release hard capsules; Tacrolimus tablets; Tacrolimus with methotrexate; | 2件: D00107 D00107
D08556 D08556 💬 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
286 | Tadalafil | Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) 13件: Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Tadalafil; Tadalafil 20 mg; Tadalafil 20 mg film-coated tablets; Tadalafil 40 mg; Tadalafil and ambrisentan upfront combination therapy; Tadalafil and sildenafil; Tadalafil citrate; Tadalafil oral suspension; Tadalafil, placebo; Tadalafil- tablet or oral suspension; Tadalafilo; | 1件: D02008 D02008 💬 |
1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 7件: 6 , 51, 75, 84, 86, 113, 210 💬 |
287 | Talampanel | Talampanel 1件: Talampanel; | 1件: D02696 D02696 💬 |
4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 2件: 2 , 6 💬 |
288 | Tavapadon | Tavapadon 4件: Tavapadon; Tavapadon 0.25mg; Tavapadon 1mg; Tavapadon 5mg; | 1件: D11431 D11431 💬 |
2件: DRD1, DRD5 💬 |
Alcoholism 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 1件: 6 💬 |
289 | Technetium Tc-99m exametazime | - | 1件: D02284 D02284 💬 |
- |
- |
006 1件: 6 💬 |
290 | Terazosin | Terazosin 2件: Terazosin; Terazosin 5 mg; | 2件: D00610 D00610
D08569 D08569 💬 |
3件: ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
291 | Tesofensine | 1. tesofensine (ns 2330) 3件: 1. tesofensine (ns 2330); Tesofensine; Tesofensine/metoprolol; | - |
- |
- |
006 2件: 6 , 193 💬 |
292 | Tolcapone | Tolcapone 1件: Tolcapone; | 1件: D00786 D00786 💬 |
1件: COMT 💬 |
Dopaminergic synapse 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 3件: 6 , 28, 127 💬 |
293 | Topiramate | Topiramate 2件: Topiramate; Topiramate (drug); | 1件: D00537 D00537 💬 |
36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 52件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 5件: 6 , 140, 144, 156, 193 💬 |
294 | Topramezone | - | - |
- |
- |
006 8件: 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
295 | Tozadenant | Tozadenant 5件: Tozadenant; Tozadenant (syn115) 120 mg bid; Tozadenant (syn115) 180 mg bid; Tozadenant (syn115) 240 mg bid; Tozadenant (syn115) 60 mg bid; | 1件: D10174 D10174 💬 |
1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
296 | Trichloroethylene | - | - |
- |
- |
006 1件: 6 💬 |
297 | Tricyclazole | - | - |
- |
- |
006 2件: 6 , 51 💬 |
298 | Trihexyphenidyl | Other: controls primary cervical dystonia (trihexyphenidyl) 3件: Other: controls primary cervical dystonia (trihexyphenidyl); Primary cervical dystonia (trihexyphenidyl); Trihexyphenidyl; | 2件: D00787 D00787
D08638 D08638 💬 |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
005 2件: 5 , 6 💬 |
299 | Trimethobenzamide | Trimethobenzamide 2件: Trimethobenzamide; Trimethobenzamide hydrochloride; | 2件: D02733 D02733
D08643 D08643 💬 |
- |
- |
006 1件: 6 💬 |
300 | Tropicamide | 0 mg tropicamide 5件: 0 mg tropicamide; 0.3 mg tropicamide; 1 mg tropicamide; 3 mg tropicamide; Tropicamide; | 1件: D00397 D00397 💬 |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 2件: 6 , 19 💬 |
301 | Tryptophan | Tryptophan 2件: Tryptophan; Tryptophan (trp) depletion; | 1件: D00020 D00020 💬 |
- |
- |
006 2件: 6 , 75 💬 |
302 | Tulobuterol | Tulobuterol 2件: Tulobuterol; Tulobuterol hydrochloride; | 1件: D02151 D02151 💬 |
1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
303 | Tyramine | Other: tyramine 2件: Other: tyramine; Tyramine; | - |
- |
- |
006 1件: 6 💬 |
304 | Tyrosine | L-tyrosine 2件: L-tyrosine; Tyrosine; | 1件: D00022 D00022 💬 |
- |
- |
006 5件: 6 , 75, 86, 111, 298 💬 |
305 | Ubidecarenone | - | 1件: D01065 D01065 💬 |
- |
- |
002 13件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 86, 113, 193, 214, 215 💬 |
306 | Ubiquinol | Ubiquinol 1件: Ubiquinol; | - |
- |
- |
006 3件: 6 , 8 , 17 💬 |
307 | Umbilical Cord Blood Hematopoietic Stem Cells | - | - |
- |
- |
002 2件: 2 , 6 💬 |
308 | Uric acid | - | - |
- |
- |
006 1件: 6 💬 |
309 | Ursodeoxycholic acid | Norursodeoxycholic acid 16件: Norursodeoxycholic acid; Tauroursodeoxycholic acid; Tauroursodeoxycholic acid capsules; Tauroursoursodeoxycholic acid, brand name tudcabil; Udca (ursodeoxycholic acid); Ursodeoxycholic acid; Ursodeoxycholic acid (udca); Ursodeoxycholic acid (urso); Ursodeoxycholic acid 300mg capsule; Ursodeoxycholic acid 300mg tablet; Ursodeoxycholic acid capsules; Ursodeoxycholic acid combination of immunosuppressive agents; Ursodeoxycholic acid combined with total glucosides of paeony; Ursodeoxycholic acid only; Ursodeoxycholic acid+low dose glucocorticoid(prednisone); Ursodiol (ursodeoxycholic acid, udca); | 1件: D00734 D00734 💬 |
1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
006 13件: 6 , 8 , 20, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬 |
310 | Valerian | Valerian 1件: Valerian; | - |
- |
- |
006 1件: 6 💬 |
311 | Valproic acid | Valproic acid 3件: Valproic acid; Valproic acid (vpa); Valproic acid and levocarnitine; | 1件: D00399 D00399 💬 |
7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬 |
312 | Varenicline | Varenicline 2件: Varenicline; Varenicline tartrate; | 1件: D08669 D08669 💬 |
2件: CHRNA4, CHRNB2 💬 |
Cholinergic synapse 3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction |
006 2件: 6 , 18 💬 |
313 | Venglustat | Venglustat 5件: Venglustat; Venglustat (gz/sar402671); Venglustat gz/sar402671; Venglustat gz402671; Venglustat malate; | 1件: D11633 D11633 💬 |
1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
006 3件: 6 , 19, 67 💬 |
314 | Venlafaxine | Efexor xl 75 mg (venlafaxine) 3件: Efexor xl 75 mg (venlafaxine); Venlafaxine; Venlafaxine hydrochloride; | 2件: D00821 D00821
D08670 D08670 💬 |
2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 3件: 6 , 13, 46 💬 |
315 | Vitamin E | Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e) 9件: Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e); Coenzyme q10 with vitamin e; Omega-3 and vitamin e supplementation; Vitamin c 10mg/kg vitamin e 10 mg/kg; Vitamin e; Vitamin e - tgps; Vitamin e 800iu; Vitamin e supplement; Vitamin e/selenium; | 1件: D02331 D02331 💬 |
- |
- |
002 12件: 2 , 6 , 13, 20, 46, 49, 90, 96, 97, 206, 299, 317 💬 |
316 | Vortioxetine | Vortioxetine 1件: Vortioxetine; | 1件: D10184 D10184 💬 |
7件: HTR1A, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E, SLC6A4 💬 |
Neuroactive ligand-receptor interaction 5件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway |
006 1件: 6 💬 |
317 | Warfarin | S-warfarin 6件: S-warfarin; The generic name is warfarin and many producers will be involved; Warfarin; Warfarin 10 mg; Warfarin sodium; Warfarin+ vitamin k; | 3件: D00564 D00564
D01280 D01280
D08682 D08682 💬 |
2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
318 | Water | 15 o water 31件: 15 o water; 15-o labeled water; 5% glucose water solution; Behavioral: diet and water adjustment; Behavioral: water tracking; Cholecalciferol concentrate (water-dispersible form); Device: manual toothbrush and water flosser (philips sonicare airfloss); Device: sonic toothbrush (philips sonicare) and water flosser (philips sonicare airfloss); Dextrose, 5% in water; High water intake; Lactose in water; Other: ad libitum water intake; Other: dead sea solar and water treatment; Other: dextrose water 5%; Other: exercise followed cold water immersion; Other: harkány medicinal water; Other: high water intake; Other: potable water; Other: water; Other: water prescription; Pl 12185/0002 & pl 12185/0005(water for injection); Procedure: water exercises; Pseudoephedrine + 480 ml water; Pseudoephedrine + 50 ml water; Sterile water; Sterile water for injection; Sterilised water for injections; Water; Water for injection; Water for injections; Water for injections, ep; | 1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
319 | Yohimbine | Yohimbine 2件: Yohimbine; Yohimbine hcl; | 1件: D08685 D08685 💬 |
3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
320 | Zoledronic acid | Lonafarnib, zoledronic acid, and pravastatin 8件: Lonafarnib, zoledronic acid, and pravastatin; Zoledronic acid; Zoledronic acid 5mg/bag 100ml inj; Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product; Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product.; Zoledronic acid kern pharma 4 mg/100 ml solution for infusion,generic medicinal product; Zoledronic acid monohydrate; Zoledronic acid, pravastatin; | 4件: D01968 D01968
D06378 D06378
D06379 D06379
D08689 D08689 💬 |
1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 10件: 6 , 13, 46, 65, 93, 95, 96, 274, 299, 333 💬 |
321 | Zolmitriptan | Zolmitriptan 1件: Zolmitriptan; | 1件: D00415 D00415 💬 |
2件: HTR1B, HTR1D 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 1件: 6 💬 |
322 | Zolpidem | Zolpidem 4件: Zolpidem; Zolpidem first dose; Zolpidem second dose; Zolpidem tartrate; | 2件: D00706 D00706
D08690 D08690 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
005 3件: 5 , 6 , 46 💬 |
323 | Zonisamide | Ad-810n (zonisamide) 3件: Ad-810n (zonisamide); Zonisamide; Zonisamide capsules; | 1件: D00538 D00538 💬 |
8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus |
006 1件: 6 💬 |
324 | Zopiclone | Doxepin and zopiclone 3件: Doxepin and zopiclone; Eszopiclone; Zopiclone; | 1件: D01372 D01372 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 1件: 6 💬 |